SCHEMBL5466150

SCHEMBL5466150

COc1cccc(CNC(=O)N2CCN(C)CC2)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.56
NAMPT P43490 1/20 0.55
KDM4E B2RXH2 3/20 0.54
TDP1 Q9NUW8 1/20 0.54
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
THRB P10828 2/20 0.50
MAPT P10636 2/20 0.49
LMNA P02545 2/20 0.49
POLB P06746 1/20 0.49
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49
RAB9A P51151 1/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471711 0.88 PKM (0.69) PKMNAMPTKDM4ETDP1MEN1
SCHEMBL13873564 0.79 EPHX2 (0.68) PKMNAMPTKDM4EMEN1KMT2A
SCHEMBL4981461 0.79 MCHR1 (0.52) NAMPTALDH1A1THRBMAPTLMNA
SCHEMBL5476543 0.79 MEN1 (0.56) PKMKDM4ETDP1MEN1KMT2A
SCHEMBL13873507 0.78 PKM (0.59) PKMNAMPTTDP1MEN1KMT2A
SCHEMBL13873650 0.78 EPHX2 (0.61) PKMNAMPTMEN1KMT2AMAPT
SCHEMBL13873690 0.78 EPHX2 (0.67) PKMNAMPTKDM4EKMT2AALDH1A1
SCHEMBL5463995 0.78 NPC1 (0.56) PKMMEN1KMT2AALDH1A1THRB
SCHEMBL13873612 0.78 EPHX2 (0.67) NAMPTMEN1KMT2AMAPTROCK2
SCHEMBL7495080 0.77 ROCK2 (0.59) KDM4EMEN1KMT2AALDH1A1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression HRH3, HRH1, HRH4 PKM 3377/4885NAMPT 3859/4885KDM4E 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.